Literature DB >> 34311992

Targeting natural killer cells to enhance vaccine responses.

Andrew Cox1, Hilal Cevik2, H Alex Feldman3, Laura M Canaday4, Nora Lakes5, Stephen N Waggoner6.   

Abstract

Vaccination serves as a cornerstone of global health. Successful prevention of infection or disease by vaccines is achieved through elicitation of pathogen-specific antibodies and long-lived memory T cells. However, several microbial threats to human health have proven refractory to past vaccine efforts. These shortcomings have been attributed to either inefficient triggering of memory T and B cell responses or to the unfulfilled need to stimulate non-conventional forms of immunological memory. Natural killer (NK) cells have recently emerged as both key regulators of vaccine-elicited T and B cell responses and as memory cells that contribute to pathogen control. We discuss potential methods to modulate these functions of NK cells to enhance vaccine success.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  T(FH); adjuvants; cytotoxicity; immunization; immunoregulation; innate lymphoid cells

Mesh:

Substances:

Year:  2021        PMID: 34311992      PMCID: PMC8364504          DOI: 10.1016/j.tips.2021.06.004

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   17.638


  105 in total

Review 1.  Natural killer cell memory in infection, inflammation and cancer.

Authors:  Adelheid Cerwenka; Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2016-01-25       Impact factor: 53.106

2.  Lymphocytes Negatively Regulate NK Cell Activity via Qa-1b following Viral Infection.

Authors:  Haifeng C Xu; Jun Huang; Aleksandra A Pandyra; Elisabeth Lang; Yuan Zhuang; Christine Thöns; Jörg Timm; Dieter Häussinger; Marco Colonna; Harvey Cantor; Karl S Lang; Philipp A Lang
Journal:  Cell Rep       Date:  2017-11-28       Impact factor: 9.423

3.  Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature.

Authors:  Laurane De Mot; Viviane Bechtold; Vanesa Bol; Andrea Callegaro; Margherita Coccia; Ahmed Essaghir; Dicle Hasdemir; Fernando Ulloa-Montoya; Emilio Siena; Age Smilde; Robert A van den Berg; Arnaud M Didierlaurent; Wivine Burny; Robbert G van der Most
Journal:  Sci Transl Med       Date:  2020-11-11       Impact factor: 17.956

Review 4.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

5.  Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.

Authors:  Lishomwa C Ndhlovu; Sandra Lopez-Vergès; Jason D Barbour; R Brad Jones; Aashish R Jha; Brian R Long; Eric C Schoeffler; Tsuyoshi Fujita; Douglas F Nixon; Lewis L Lanier
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

6.  Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination.

Authors:  Carolyn M Boudreau; Wen-Han Yu; Todd J Suscovich; H Keipp Talbot; Kathryn M Edwards; Galit Alter
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 7.  Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells.

Authors:  Maria Carmen Ochoa; Luna Minute; Inmaculada Rodriguez; Saray Garasa; Elisabeth Perez-Ruiz; Susana Inogés; Ignacio Melero; Pedro Berraondo
Journal:  Immunol Cell Biol       Date:  2017-02-21       Impact factor: 5.126

8.  Migratory Dendritic Cells, Group 1 Innate Lymphoid Cells, and Inflammatory Monocytes Collaborate to Recruit NK Cells to the Virus-Infected Lymph Node.

Authors:  Eric Wong; Ren-Huan Xu; Daniel Rubio; Avital Lev; Colby Stotesbury; Min Fang; Luis J Sigal
Journal:  Cell Rep       Date:  2018-07-03       Impact factor: 9.423

Review 9.  Trained immunity: A program of innate immune memory in health and disease.

Authors:  Mihai G Netea; Leo A B Joosten; Eicke Latz; Kingston H G Mills; Gioacchino Natoli; Hendrik G Stunnenberg; Luke A J O'Neill; Ramnik J Xavier
Journal:  Science       Date:  2016-04-21       Impact factor: 47.728

10.  Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.

Authors:  Veron Ramsuran; Vivek Naranbhai; Amir Horowitz; Ying Qi; Maureen P Martin; Yuko Yuki; Xiaojiang Gao; Victoria Walker-Sperling; Gregory Q Del Prete; Douglas K Schneider; Jeffrey D Lifson; Jacques Fellay; Steven G Deeks; Jeffrey N Martin; James J Goedert; Steven M Wolinsky; Nelson L Michael; Gregory D Kirk; Susan Buchbinder; David Haas; Thumbi Ndung'u; Philip Goulder; Peter Parham; Bruce D Walker; Jonathan M Carlson; Mary Carrington
Journal:  Science       Date:  2018-01-04       Impact factor: 47.728

View more
  7 in total

1.  Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine.

Authors:  Tomohiro Takano; Miwa Morikawa; Yu Adachi; Kiyomi Kabasawa; Nicolas Sax; Saya Moriyama; Lin Sun; Masanori Isogawa; Ayae Nishiyama; Taishi Onodera; Kazutaka Terahara; Keisuke Tonouchi; Masashi Nishimura; Kentaro Tomii; Kazuo Yamashita; Takayuki Matsumura; Masaharu Shinkai; Yoshimasa Takahashi
Journal:  Cell Rep Med       Date:  2022-04-22

2.  NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.

Authors:  Caroline Boulouis; Iva Filipovic; David Wullimann; Angelica Cuapio; Tobias Kammann; Tiphaine Parrot; Puran Chen; Mira Akber; Yu Gao; Quirin Hammer; Benedikt Strunz; André Pérez Potti; Olga Rivera Ballesteros; Joshua Lange; Jagadeeswara Rao Muvva; Peter Bergman; Ola Blennow; Lotta Hansson; Stephan Mielke; Piotr Nowak; Gunnar Söderdahl; Anders Österborg; C I Edvard Smith; Gordana Bogdanovic; Sandra Muschiol; Fredrika Hellgren; Karin Loré; Michal J Sobkowiak; Giorgio Gabarrini; Katie Healy; Margaret Sällberg Chen; Evren Alici; Niklas K Björkström; Marcus Buggert; Per Ljungman; Johan K Sandberg; Soo Aleman; Hans-Gustaf Ljunggren
Journal:  Mol Med       Date:  2022-02-08       Impact factor: 6.354

3.  Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.

Authors:  Ching-Fen Shen; Chia-Liang Yen; Yi-Chen Fu; Chao-Min Cheng; Tzu-Chi Shen; Pei-De Chang; Kuang-Hsiung Cheng; Ching-Chuan Liu; Yu-Tzu Chang; Po-Lin Chen; Wen-Chien Ko; Chi-Chang Shieh
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

4.  Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA COVID-19 vaccine.

Authors:  Davide Flego; Simone Cesaroni; Giulio F Romiti; Bernadette Corica; Ramona Marrapodi; Noemi Scafa; Francesca Maiorca; Ludovica Lombardi; Davide Pallucci; Fabio Pulcinelli; Valeria Raparelli; Marcella Visentini; Roberto Cangemi; Silvia Piconese; Domenico Alvaro; Antonella Polimeni; Stefania Basili; Lucia Stefanini
Journal:  J Thromb Haemost       Date:  2022-01-26       Impact factor: 16.036

Review 5.  NK Cells in Protection from HIV Infection.

Authors:  Nicole F Bernard; Khlood Alsulami; Erik Pavey; Franck P Dupuy
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

Review 6.  Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control.

Authors:  Nicole F Bernard; Sanket Kant; Zahra Kiani; Cécile Tremblay; Franck P Dupuy
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

Review 7.  How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells.

Authors:  Anna Aiello; Mattia Emanuela Ligotti; Maider Garnica; Giulia Accardi; Anna Calabrò; Fanny Pojero; Hugo Arasanz; Ana Bocanegra; Ester Blanco; Luisa Chocarro; Miriam Echaide; Leticia Fernandez-Rubio; Pablo Ramos; Sergio Piñeiro-Hermida; Grazyna Kochan; Nahid Zareian; Farzin Farzaneh; David Escors; Calogero Caruso; Giuseppina Candore
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.